Table 2.
Acute and delayed toxicity after treatment
| EFI | Pelvis only | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Grade | II | III | IV | Total | II | III | IV | Total | P value |
| Acute toxicity (CTCEA 2.0) | |||||||||
| Leukocytes | 18 | 35 | 4 | 57 | 18 | 23 | 0 | 41 | 0,003 |
| Neutrophils | 28 | 16 | 2 | 46 | 16 | 10 | 3 | 29 | 0,004 |
| Platelets | 17 | 8 | 0 | 25 | 11 | 6 | 0 | 17 | 0,152 |
| Lymphopenia | 2 | 61 | 0 | 63 | 23 | 39 | 0 | 62 | 0,982 |
| Hemoglobin | 31 | 16 | 3 | 50 | 30 | 4 | 2 | 36 | 0.015 |
| Frequent urination | 28 | 2 | 0 | 30 | 28 | 2 | 0 | 30 | 0,461 |
| Diarrhea | 12 | 7 | 0 | 19 | 18 | 4 | 0 | 22 | 0,332 |
| Delayed toxicity (RTOG/EORTC1987) | |||||||||
| Urinary system | 5 | 3 | 0 | 8 | 3 | 1 | 0 | 4 | 0.190 |
| Lower digestive tract | 6 | 1 | 0 | 7 | 4 | 1 | 0 | 5 | 0,392 |